Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean A Regier

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
JAMA Network Open|August 11, 2021
Canadian Regulatory and Health Technology Assessment for Malignant Hematology and Oncology Indications Compared With the US Food and Drug Administration Accelerated Approval ProgramCheryl Ho, Howard J Lim, Dean A Regier
Current Oncology (Toronto, Ont.)|February 24, 2022
FDA Accelerated Approval for Malignant Hematology and Oncology Indications in the Canadian EnvironmentCheryl Ho, Howard J Lim, Dean A Regier
Journal of Community Genetics|July 6, 2019
Allocating healthcare resources to genomic testing in Canada: latest evidence and current challengesDeirdre Weymann, Nick Dragojlovic, Samantha Pollard, et al.
American Journal of Human Genetics|April 20, 2010
Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disabilityDean A Regier, Jan M Friedman, Carlo A Marra
Journal of Personalized Medicine|January 21, 2022
Stakeholder Perspectives on Navigating Evidentiary and Decision Uncertainty in Precision OncologySamantha Pollard, Jessica Dunne, Sarah Costa, et al.
Healthcare Policy = Politiques De Sante|March 23, 2022
The Importance of and Challenges with Adopting Life-Cycle Regulation and Reimbursement in CanadaMelanie McPhail, Christopher McCabe, Dean A Regier, et al.
Personalized Medicine|July 23, 2025
A scoping review of the cost-effectiveness of precision treatment in chronic lymphocytic leukemiaJesman Punian, Morgan Ehman, Deirdre Weymann, et al.
Frontiers in Medicine|September 18, 2025
How life-cycle real-world evidence can bridge evidentiary gaps in precision oncologyEmanuel Krebs, Deirdre Weymann, Tania Bubela, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 3, 2024
Next-generation sequencing in oncology: challenges in economic evaluationsMorgan Ehman, Jesman Punian, Deirdre Weymann, et al.
BMJ Global Health|October 17, 2024
Qualitative genomic research with Indigenous peoples: a scoping review of participatory practiceMorgan Ehman, Nadine R Caron, Laurie Montour, et al.
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
JAMA Network Open|August 11, 2021
Canadian Regulatory and Health Technology Assessment for Malignant Hematology and Oncology Indications Compared With the US Food and Drug Administration Accelerated Approval ProgramCheryl Ho, Howard J Lim, Dean A Regier
Current Oncology (Toronto, Ont.)|February 24, 2022
FDA Accelerated Approval for Malignant Hematology and Oncology Indications in the Canadian EnvironmentCheryl Ho, Howard J Lim, Dean A Regier
Journal of Community Genetics|July 6, 2019
Allocating healthcare resources to genomic testing in Canada: latest evidence and current challengesDeirdre Weymann, Nick Dragojlovic, Samantha Pollard, et al.
American Journal of Human Genetics|April 20, 2010
Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disabilityDean A Regier, Jan M Friedman, Carlo A Marra
Journal of Personalized Medicine|January 21, 2022
Stakeholder Perspectives on Navigating Evidentiary and Decision Uncertainty in Precision OncologySamantha Pollard, Jessica Dunne, Sarah Costa, et al.
Healthcare Policy = Politiques De Sante|March 23, 2022
The Importance of and Challenges with Adopting Life-Cycle Regulation and Reimbursement in CanadaMelanie McPhail, Christopher McCabe, Dean A Regier, et al.
Personalized Medicine|July 23, 2025
A scoping review of the cost-effectiveness of precision treatment in chronic lymphocytic leukemiaJesman Punian, Morgan Ehman, Deirdre Weymann, et al.
Frontiers in Medicine|September 18, 2025
How life-cycle real-world evidence can bridge evidentiary gaps in precision oncologyEmanuel Krebs, Deirdre Weymann, Tania Bubela, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 3, 2024
Next-generation sequencing in oncology: challenges in economic evaluationsMorgan Ehman, Jesman Punian, Deirdre Weymann, et al.
BMJ Global Health|October 17, 2024
Qualitative genomic research with Indigenous peoples: a scoping review of participatory practiceMorgan Ehman, Nadine R Caron, Laurie Montour, et al.
Pageof 13